$TBI

TrueBlue, Inc. Q2 2026 Earnings Call Summary

TrueBlue reported double-digit Q2 2026 revenue growth driven by a return to growth in general on-demand and expansion in skilled verticals. It shifted to a territory-based on-demand model, with energy revenue nearly doubling for a fifth straight growth quarter. Q3 revenue growth guidance is 7% to 11%. Gross margin fell to 20.7% from 23.6% due to nonrecurring benefits and mix effects.

Original reporting
Published Aug 6, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TrueBlue, Inc. Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$TBIBullishMed
01

Why it matters

Traders can update near-term expectations using the explicit Q3 revenue growth range (7% to 11%) and management’s margin outlook, while also weighing gross margin headwinds from non-recurrence items and mix effects tied to energy work.

02

Market read

The call combines a demand recovery narrative with quantified Q3 growth and margin guidance, plus identifiable energy catalysts (data centers and battery storage) and cost leverage (SG&A down 7%).

03

What to watch

The Tacoma headquarters write-down and essentially zero U.S. tax benefits from deferred tax valuation allowance highlight balance-sheet and tax headwinds that may cap multiple expansion even with revenue growth.

Relevance 7/10Novelty 6/10Timing: post-market earnings call, actionable for next-day positioning

Background

This is a Q2 2026 earnings call summary for TrueBlue, focusing on the on-demand operating model shift, vertical performance, and forward guidance.

Company-level read

Ticker impact

$TBIBullishMedium confidence
Context

TrueBlue guides Q3 revenue growth of 7% to 11% and expects steady sequential gross margins and expanding adjusted EBITDA margins.

Expected impact

Likely supportive for the stock versus prior expectations if investors were focused on margin pressure and demand recovery.

Evidence & confidence

Management cites territory-based on-demand model returning growth across regions, energy nearly doubling, and SG&A down 7% despite revenue growth, offset by gross margin decline from non-recurrence items.

Market effects

Signals improving demand in staffing and skilled trades, with energy vertical strength tied to data centers and battery storage.

Management highlights broad-based recovery with particular strength in the West, including California, Florida, and Texas.

Limited direct global spillover, aside from UK Armed Forces engagement ramping toward 2027.

Counterpoint

Gross margin fell to 20.7% from 23.6% due to non-recurrence of prior-year benefits and subsidy effects, which could mean underlying profitability is less resilient than the margin expansion narrative suggests.

Key entities

  • TrueBlue, Inc.

    Provides Q3 revenue growth guidance (7% to 11%), margin expectations, and segment drivers including energy and skilled trades.

  • JobStack and Affinix

    Digital transformation initiatives with AI-powered features aimed at reducing manual steps and improving time-to-fill.

  • UK Armed Forces engagement

    In ramping phase, expected to reach full value contribution in 2027.

Related articles

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.